Bruyere O - Search Results

1

Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis.

Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Richy F, et al. Among authors: bruyere o. Arch Intern Med. 2003 Jul 14;163(13):1514-22. doi: 10.1001/archinte.163.13.1514. Arch Intern Med. 2003. PMID: 12860572

2

Radiologic features poorly predict clinical outcomes in knee osteoarthritis.

Bruyere O, Honore A, Rovati LC, Giacovelli G, Henrotin YE, Seidel L, Reginster JY. Bruyere O, et al. Scand J Rheumatol. 2002;31(1):13-6. doi: 10.1080/030097402317255309. Scand J Rheumatol. 2002. PMID: 11922194 Clinical Trial.

3

Fracture prevention in postmenopausal women.

Bruyere O, Reginster JY. Bruyere O, et al. Clin Evid. 2002 Jun;(7):979-82. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):1089-102. PMID: 12230720 Updated. Review. No abstract available.

4

Fracture prevention in postmenopausal women.

Bruyere O, Reginster JY, Edwards J. Bruyere O, et al. Clin Evid. 2002 Dec;(8):1089-102. Clin Evid. 2002. Update in: Clin Evid. 2003 Jun;(9):1186-202. PMID: 12603931 Free article. Updated. Review. No abstract available.

5

Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.

Bruyere O, Collette J, Delmas P, Rouillon A, Roux C, Seidel L, Richy F, Reginster JY. Bruyere O, et al. Maturitas. 2003 Apr 25;44(4):259-65. doi: 10.1016/s0378-5122(03)00042-2. Maturitas. 2003. PMID: 12697366

6

Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review.

Richy F, Bousquet J, Ehrlich GE, Meunier PJ, Israel E, Morii H, Devogelaer JP, Peel N, Haim M, Bruyere O, Reginster JY. Richy F, et al. Among authors: bruyere o. Osteoporos Int. 2003 May;14(3):179-90. doi: 10.1007/s00198-003-1398-z. Epub 2003 Apr 23. Osteoporos Int. 2003. PMID: 12730758 Review.

7

Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis.

Bruyere O, Collette JH, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, Seidel L, Reginster JY. Bruyere O, et al. J Rheumatol. 2003 May;30(5):1043-50. J Rheumatol. 2003. PMID: 12734904

8

Impact of the joint space width measurement method on the design of knee osteoarthritis studies.

Bruyère O, Henrotin YE, Honoré A, Rovati LC, Seidel L, Dardenne C, Reginster JY. Bruyère O, et al. Aging Clin Exp Res. 2003 Apr;15(2):136-41. doi: 10.1007/BF03324491. Aging Clin Exp Res. 2003. PMID: 12889845 Free article.

9

New perspectives in the management of osteoarthritis. structure modification: facts or fantasy?

Reginster JY, Bruyere O, Henrotin Y. Reginster JY, et al. Among authors: bruyere o. J Rheumatol Suppl. 2003 Aug;67:14-20. J Rheumatol Suppl. 2003. PMID: 12926646 Review.

10

Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis.

Reginster JY, Bruyere O, Lecart MP, Henrotin Y. Reginster JY, et al. Among authors: bruyere o. Curr Opin Rheumatol. 2003 Sep;15(5):651-5. doi: 10.1097/00002281-200309000-00022. Curr Opin Rheumatol. 2003. PMID: 12960496 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters